A mathematical model of a drug transport after rapid injection is given. It takes into account three processes:
Introduction
Drug protein binding is an reversible attachment resulting from electrostatic Londonvan der Waals's forces, hydrogen bond or their combinations. This reaction satisfy the law of mass action and lasts milliseconds (1) . Unbound fraction of drug in vitro is calculated as a quotient of free drug serum concentration and total serum concentration of drug in the closed system (vials space) and given in percents. In design of molecular structures of new drugs, data from drug protein binding in vitro is not often used successfully (2) . This approach was questioned by Smith and co-workers, authors of "a free drug hypothesis." They indicated that in human organism (open system), it is free drug concentration, not unbound fraction of drug, that should be considered (3) . Concise review of quantification methods used to assessing a degree of drug protein binding was described by Howard and co-workers (4).
Drug molecules weakly bonded with plasma protein may be displaced by strongly bonded molecules. This is an example of protein-drug pharmacokinetic interaction which may be simulated as Christensen and co-workers described (5) . Interesting phenomenon of decreasing unbound fraction of drug when the total drug concentration increased in the limit range was recently described by Breshkovsky (6) . He suggested the hypothesis of a strong binding site activation by weaker bonding site, present in protein molecules.
Free drug concentration changes in time in a living organism because of dissociation of protein-drug complex, distribution and elimination processes and it has influence on the potency of pharmacological effect.
How drug protein binding changes affect the pharmacokinetic and pharmacodynamic parameters has been the problem discussed in professional literature for many years.
According to some earlier opinions, the drug protein binding in vivo was not clinically significant. There is an opinion that drug protein binding changes affect the clinical outcome due to changes of clearance of a free drug There is a need to have a research tool for simulating drug interactions in all effect compartments. In the work presented below we proposed the mathematical modelling of a sequence of processes after intravenous drug administration. 
Basic equations
The above equations describe the time evolution in an uniform system without external sources.
Now, the elimination of a drug is modeled by an additional source term in the balance law ሺ1ሻ. In the simplest possible version, such additional source term can by modeled by the term proportional to ‫ݏ‬ሺ‫ݐ‬ሻ and the "strength" of a source can be measured by the proportionality coefficient ߙ. Therefore, the resulting equations are now
The equations ( ) ( ) Let ܰሺ‫ݐ‬ሻ denote the nomer of molecules of a drug in a peripherial compartment.
In order to formulate the simplest possible dynamical model of the transport processes between both compartments let us assume that the elimination of a drugi is "switched out".
Then the conservation law for the transport of the free fraction of a drug between both compartments is
( )
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Every model of the transport processes between both compartments should identically satisfy the condition ( ) 7 . The simplest such model depends
On the two parameters and assumes that the volume of the peripherial compartment is ܸ ݂݂݁ and that ܰሺ‫ݐ‬ሻ molecules are distributed with a uniform density ݊ሺ‫ݐ‬ሻ ( ) ( )
The explicit form of this model is
where the real parameter ߚ models the rate of the transport processes between both compartments. Now one can see that the final system of evolution equations for the drug transport is 
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In future we hope to interprete the solutions of this system in terms of the experimental results.
